Literature DB >> 3064599

Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.

F Magrini1, P Reggiani, N Roberts, R Meazza, M Ciulla, A Zanchetti.   

Abstract

Angiotensin is a potent coronary vasoconstrictor, but little is known of the effects of long-term activation of the renin-angiotensin system on coronary reserve in humans. The effects of exercise on coronary hemodynamics were determined in eight patients with mild essential uncomplicated hypertension, before and after treatment with furosemide (50 mg, to ensure activation of the renin-angiotensin system). Coronary sinus blood flow was measured by thermodilution technique, intra-arterial blood pressure was measured from the ascending aorta, and plasma renin activity was determined by radioimmunoassay. Oxygen supply and demand were derived (using coronary sinus blood flow multiplied by the arteriovenous oxygen difference to equal oxygen supply and heart rate multiplied by the mean systolic blood pressure to equal oxygen demand) both at rest and during isometric exercise (handgrip to 50 percent of maximal effort for three minutes). The study was a single-blind crossover (furosemide versus placebo) design. Furosemide produced a significant reduction in coronary sinus blood flow, associated with an increase in coronary vascular resistance. Changes in mean arterial pressure and heart rate were insignificant. Slight reductions in plasma volume and mean right atrial pressure were observed. During isometric exercise, the increase in oxygen supply for a given increment in oxygen demand was attenuated by furosemide. The contribution of the renin-angiotensin system to this effect was determined by the short-term administration of 25 mg of the angiotensin converting enzyme inhibitor captopril. Forty-five minutes after oral captopril, coronary reserve was restored to pretreatment values. In conclusion, furosemide modulates coronary reserve, and it is likely that this is because furosemide mediates activation of renin-angiotensin system, thus reducing the vasodilatory capacity of the coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064599     DOI: 10.1016/0002-9343(88)90205-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Management of hypertension in patients with left ventricular hypertrophy.

Authors:  Cesare Cuspidi; Carla Sala; Alberto Zanchetti
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 2.  Blood pressure-lowering efficacy of loop diuretics for primary hypertension.

Authors:  Vijaya M Musini; Pouria Rezapour; James M Wright; Ken Bassett; Ciprian D Jauca
Journal:  Cochrane Database Syst Rev       Date:  2015-05-22

Review 3.  The renin-angiotensin system and coronary vasomotion.

Authors:  G Ertl; K Hu; W R Bauer; B Bauer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  The renin-angiotensin system and the heart: a historical review.

Authors:  S J Cleland; J L Reid
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

5.  ACE inhibitors and cardioprotection.

Authors:  A Zanchetti
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

6.  Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.

Authors:  R C Sobti; Nishi Maithil; Hitender Thakur; Yashpaul Sharma; K K Talwar
Journal:  Mol Cell Biochem       Date:  2010-04-03       Impact factor: 3.396

7.  Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture.

Authors:  H Matsubara; M Kanasaki; S Murasawa; Y Tsukaguchi; Y Nio; M Inada
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 8.  Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.

Authors:  O Parodi; D Neglia; G Sambuceti; C Marabotti; C Palombo; L Donato
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  [Hypertensive heart disease and microangiopathy].

Authors:  M Kelm; B E Strauer
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

10.  Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.

Authors:  A Pipilis; M Flather; R Collins; A Hargreaves; T Kolettis; N Boon; C Foster; P Appleby; P Sleight
Journal:  Br Heart J       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.